Skip to content
Contact
Our technology

Making phage products viable

NexaBiome Life Sciences has developed several complementary technologies that address key barriers to the development of new antimicrobials, specifically in the development of effective bacteriophage products.

Plasma glowing inside a vacuum chamber
Stabilisation

Keeping phages stable and active

The keystone of our technology is a patented method of stabilising phages by attaching them to substrates. NexaBiome Life Sciences uses plasma treatment to "activate" substrates, making them reactive and enabling phages to bind while maintaining viability. This binding stabilises the phages, allowing them to remain active at room temperature.

The latest generation of this patented technology works with almost any substrate, including wound dressings, catheters and other in-dwelling devices. Stabilised phages can also be attached to powders, allowing them to be incorporated into gels or creams.

How stabilisation works
  1. Activate Plasma treatment activates the substrate
  2. Bind Phages bind while remaining viable
  3. Stabilise Bound phages remain active at room temperature
Works with
  • Wound dressings
  • Catheters
  • In-dwelling devices
  • Powders (for gels and creams)
A gloved hand holding an agar plate covered in bacteriophage plaques
Selection

Finding the right phages

In addition to its stabilisation technology, NexaBiome Life Sciences has developed an approach to selecting phage cocktails under conditions that more closely reflect natural infection. This helps identify phages with the greatest potential against target bacteria, rather than relying solely on performance under conventional laboratory conditions.

A complete approach

These technologies, combined with our specialist experience in phage development, address key barriers to creating viable phage products.

We are unlocking the full potential of phages as effective, sustainable antimicrobials for hard-to-treat bacterial infections that can have a profound impact on human health.

Next: diabetic foot infections

Targeting an unmet need

Diabetic foot infections can be difficult to treat, particularly when resistant bacteria and biofilms are involved.

Learn more